Latest National Institute of Allergy and Infectious Diseases Stories
Scientists at the National Institutes of Health have identified several factors in people infected with the hepatitis C virus that may predict whether the unusually rapid progression of disease from initial infection to severe liver conditions, such as cirrhosis, will occur.
Researchers at Baylor College of Medicine will receive up to $6.2 million over five years from the National Institute Of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a vaccine for severe acute respiratory syndrome, commonly called SARS.
Scientists have identified a new HIV-suppressing protein in the blood of people infected with the virus. In laboratory studies, the protein, called CXCL4 or PF-4, binds to HIV such that it cannot attach to or enter a human cell.
The FDA has announced its approval of the antibacterial agent levofloxacin, or “Levaquin,” to treat and prevent the plague. Manufactured by Johnson & Johnson, Levaquin was approved under the FDA’s Animal Efficacy rule which allows results from animal testing to be studied if such tests on humans aren’t ethical or feasible.
National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) epidemics in most of Asia.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.